Matches in Nanopublications for { ?s ?p "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP971848.RAVF5vmqMTFgAhr34hlp9hk9GlPhN5X7VnWiwR8cahSuY130_assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971848.RAVF5vmqMTFgAhr34hlp9hk9GlPhN5X7VnWiwR8cahSuY130_provenance.
- NP971916.RAUchDqM8q7vLgA4CJkCW9R34xd1DqSUjyX6kZfWBxhEM130_assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971916.RAUchDqM8q7vLgA4CJkCW9R34xd1DqSUjyX6kZfWBxhEM130_provenance.
- assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP867911.RAgho3glzDWhy2_KEOQulcX07K83oWTJqNEOdW3YzkGqM130_assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867911.RAgho3glzDWhy2_KEOQulcX07K83oWTJqNEOdW3YzkGqM130_provenance.
- NP867914.RAk4QxMP2nRARUIQVP1EVHBnJrdBdannr2ZaEsph1Ur6o130_assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867914.RAk4QxMP2nRARUIQVP1EVHBnJrdBdannr2ZaEsph1Ur6o130_provenance.
- NP867913.RAHcaSgy9MhcDAc4HQ_fKHpGmEC4aYNXldlg2tt00Cca4130_assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867913.RAHcaSgy9MhcDAc4HQ_fKHpGmEC4aYNXldlg2tt00Cca4130_provenance.
- NP867915.RAylvFYlTl0_EPxq7nzWQPX17XsdwXNBVnZOE9jJuDTo0130_assertion description "[Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867915.RAylvFYlTl0_EPxq7nzWQPX17XsdwXNBVnZOE9jJuDTo0130_provenance.